Prestige Consumer Healthcare
PBH
287 hedge funds and large institutions have $2.57B invested in Prestige Consumer Healthcare in 2022 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 117 increasing their positions, 87 reducing their positions, and 24 closing their positions.
4,760% more call options, than puts
Call options by funds: $243K | Put options by funds: $5K
79% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 24
34% more repeat investments, than reductions
Existing positions increased: 117 | Existing positions reduced: 87
6% more funds holding
Funds holding: 272 → 287 (+15)
0.54% less ownership
Funds ownership: 100.88% → 100.34% (-0.54%)
15% less capital invested
Capital invested by funds: $3.03B → $2.57B (-$454M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$58M |
| 2 |
RCAMU
Rothschild & Co Asset Management US
Stamford,
Connecticut
|
+$15.3M |
| 3 |
Millennium Management
New York
|
+$8.55M |
| 4 |
Goldman Sachs
New York
|
+$5.92M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$5.72M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCAM
Turtle Creek Asset Management
Toronto,
Ontario, Canada
|
-$76.8M |
| 2 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$51.5M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$29.3M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$9.73M |
| 5 |
FP
Foundry Partners
Minneapolis,
Minnesota
|
-$8.65M |
PBH Hedge Fund Activity: Q1 2022 in Review
287 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Prestige Consumer Healthcare (PBH) for Q1 2022, worth a combined $2.57B — down 15% from $3.03B a quarter earlier.
Buyers outnumbered sellers: 43 funds opened new PBH positions and 24 closed out — a net gain of 19 holders — while 117 added to existing stakes and 87 trimmed.
The largest buyer was BlackRock, adding an estimated $58M. The largest seller was Turtle Creek Asset Management, cutting an estimated $76.8M.
- 287 institutional investors held Prestige Consumer Healthcare (PBH) as of Q1 2022, up from 272 in Q4 2021.
- Funds reported $2.57B of Prestige Consumer Healthcare stock for Q1 2022, down 15% quarter-over-quarter.
- 43 funds opened new Prestige Consumer Healthcare positions in Q1 2022 and 24 closed out, a net change of +19 holders.
- The largest Prestige Consumer Healthcare buyer in Q1 2022 was BlackRock, an estimated $58M added.
- The largest Prestige Consumer Healthcare seller in Q1 2022 was Turtle Creek Asset Management, an estimated $76.8M sold.
Based on aggregated 13F filings for Q1 2022.